Mersana Therapeutics
Price & Volume
Stats
See more52W Range | $0.25-$3.63 |
Market Cap | $49.8M |
Shares Short | 10M |
Financials
See moreRevenue (12 Mos) | $40.4M |
Revenue Growth (YoY) | 52.9% |
Gross Profit (12 Mos) | -$32.5M |
Diluted EPS | -$0.56 |
News
See moreYahoo Finance • 9 days ago
Mersana Therapeutics Announces Upcoming Emi-Le Oral and Poster Presentations at ASCO 2025 Annual Meeting
Yahoo Finance • 28 days ago
Mersana Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • last month
Mersana Therapeutics Announces Upcoming Oral Presentation of Emi-Le Clinical Data at European Society for Medical Oncology (ESMO) Breast Cancer 2025 Annual Congress
Yahoo Finance • 2 months ago
Mersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2024 Financial Results
About
CEO | Dr. Martin H. Huber M.D. |
Address | 840 Memorial Drive, Cambridge, MA, United States, 02139 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 102 |
